Colchicine, when given in addition to conventional therapy, was more effective than placebo in reducing the incidence of recurrence and the persistence of symptoms of pericarditis in a randomised ...

BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke or high-risk TIA, according to the results of the CONVINCE trial. Through ...

In addition, there were no significant differences in any of the individual components of the composite endpoint. A significant reduction in C-reactive protein (CRP), a marker for inflammation, was ...

Colchicine oral tablet is available as both a generic and brand-name drug. Brand name Colcrys. It also comes in capsules that are also available as both a generic and brand-name drug. Brand name: ...

IMPROVEMENT from colchicine therapy in patients with arthritic symptoms has always been accepted as indicative of gout. 1–3 Other arthritides supposedly have not responded satisfactorily to this ...

Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...

Colchicine comes as an oral tablet that you swallow. It’s available in one strength: 0.6 milligrams (mg). Colchicine oral tablet also comes in the brand name version Colcrys. Other brand-name versions ...